Jeffrey Kralstein

1.2k total citations · 1 hit paper
12 papers, 913 citations indexed

About

Jeffrey Kralstein is a scholar working on Gastroenterology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jeffrey Kralstein has authored 12 papers receiving a total of 913 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Gastroenterology, 8 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jeffrey Kralstein's work include Gastroesophageal reflux and treatments (7 papers), Gastrointestinal motility and disorders (6 papers) and Eosinophilic Esophagitis (3 papers). Jeffrey Kralstein is often cited by papers focused on Gastroesophageal reflux and treatments (7 papers), Gastrointestinal motility and disorders (6 papers) and Eosinophilic Esophagitis (3 papers). Jeffrey Kralstein collaborates with scholars based in United States, Switzerland and Poland. Jeffrey Kralstein's co-authors include John F. Johanson, William H. Frishman, Kristijan H. Kahler, David L. Earnest, Ralph Quimbo, Lin Chang, Chaitanya Sarawate, Michael A. Shetzline, In‐Sun Choi and Jan Tack and has published in prestigious journals such as The American Journal of Gastroenterology, American Heart Journal and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Jeffrey Kralstein

12 papers receiving 862 citations

Hit Papers

Chronic constipation: a survey of the patient perspective 2007 2026 2013 2019 2007 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chronic constipation: a survey of the patient perspective
    2007 498 citations John F. Johanson, Jeffrey Kralstein Alimentary Pharmacology & Therapeutics profile →

Peers

Jeffrey Kralstein
Sandro Passaretti Italy
Sean Harbison United States
Fred Datz United States
Dominiek De Wulf Belgium
Scott S. Malinowski United States
S. B. Doldi Italy
Kalyani Maganti United States
Τhomai Karagiozoglou‐Lampoudi Greece
Kim Brinch Denmark
Karamollah Toolabi Iran
Sandro Passaretti Italy
Jeffrey Kralstein
Citations per year, relative to Jeffrey Kralstein Jeffrey Kralstein (= 1×) peers Sandro Passaretti

Countries citing papers authored by Jeffrey Kralstein

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Kralstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Kralstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Kralstein more than expected).

Fields of papers citing papers by Jeffrey Kralstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Kralstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Kralstein. The network helps show where Jeffrey Kralstein may publish in the future.

Co-authorship network of co-authors of Jeffrey Kralstein

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Kralstein. A scholar is included among the top collaborators of Jeffrey Kralstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Kralstein. Jeffrey Kralstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Loughlin, Jeanne, et al.. (2010). Tegaserod and the Risk of Cardiovascular Ischemic Events: An Observational Cohort Study. Journal of Cardiovascular Pharmacology and Therapeutics. 15(2). 151–157. 65 indexed citations
2.
Vakil, Nimish, Loren Laine, Nicholas J. Talley, et al.. (2008). Tegaserod Treatment for Dysmotility-Like Functional Dyspepsia: Results of Two Randomized, Controlled Trials. The American Journal of Gastroenterology. 103(8). ???–???. 86 indexed citations
3.
Kahler, Kristijan H., et al.. (2007). Patients with irritable bowel syndrome or constipation have an increased risk for ischaemic colitis. Alimentary Pharmacology & Therapeutics. 25(6). 681–692. 61 indexed citations
4.
Majewski, Marek, Irene Sarosiek, Stanley A. Edlavitch, et al.. (2007). Significant Enhancement of Esophageal Pre-Epithelial Defense by Tegaserod: Implications for an Esophagoprotective Effect. Clinical Gastroenterology and Hepatology. 5(4). 430–438. 15 indexed citations
5.
Chang, Lin, Kristijan H. Kahler, Chaitanya Sarawate, Ralph Quimbo, & Jeffrey Kralstein. (2007). Assessment of potential risk factors associated with ischaemic colitis. Neurogastroenterology & Motility. 20(1). 36–42. 53 indexed citations
6.
Johanson, John F. & Jeffrey Kralstein. (2007). Chronic constipation: a survey of the patient perspective. Alimentary Pharmacology & Therapeutics. 25(5). 599–608. 498 indexed citations breakdown →
7.
Proskin, Howard M., et al.. (2006). Effect of Tegaserod on Esophageal Pain Threshold, Regurgitation, and Symptom Relief in Patients With Functional Heartburn and Mechanical Sensitivity. Clinical Gastroenterology and Hepatology. 4(4). 442–450. 54 indexed citations
8.
Suh, Dong‐Churl, et al.. (2005). Patients Less Than 65 Years of Age Suffering from Irritable Bowel Syndrome or Constipation Have a High Risk of Being Diagnosed with Ischemic Colitis. The American Journal of Gastroenterology. 100. S344–S345. 2 indexed citations
9.
Rodriguez-Stanley, Sheila, et al.. (2005). An Exploratory Open Label Trial of Tegaserod in Non-Erosive GERD Patients with Incomplete Response to PPIʼs. The American Journal of Gastroenterology. 100. S38–S38. 2 indexed citations
10.
Kralstein, Jeffrey, et al.. (2000). Somatostatinoma of the Ampulla of vater in celiac sprue. Journal of Gastrointestinal Surgery. 4(4). 388–391. 3 indexed citations
11.
Kralstein, Jeffrey & William H. Frishman. (1987). Malignant pericardial diseases: Diagnosis and treatment. American Heart Journal. 113(3). 785–790. 64 indexed citations
12.
Kralstein, Jeffrey & William H. Frishman. (1987). Malignant Pericardial Diseases: Diagnosis and Treatment. Cardiology Clinics. 5(4). 583–589. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sandro Passaretti Breakdown of academic impact, for papers by Sean Harbison Breakdown of academic impact, for papers by Fred Datz Breakdown of academic impact, for papers by Dominiek De Wulf Breakdown of academic impact, for papers by Scott S. Malinowski Breakdown of academic impact, for papers by S. B. Doldi Breakdown of academic impact, for papers by Kalyani Maganti Breakdown of academic impact, for papers by Τhomai Karagiozoglou‐Lampoudi Breakdown of academic impact, for papers by Kim Brinch Breakdown of academic impact, for papers by Karamollah Toolabi
Rankless by CCL
2026